Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aimee D Wauters

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Children (Basel, Switzerland)|November 27, 2025
Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in ChildrenHussein Zaitoon, Aimee D Wauters, Luisa M Rodriguez, et al.
Children (Basel, Switzerland)|May 27, 2026
Reply to Improda, N.; Ballarin, G. Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on "Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. <i>Children</i> 2025, <i>12</i>, 1427"Hussein Zaitoon, Aimee D Wauters, Luisa M Rodriguez, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 7, 2019
Adherence to multiple medications in the TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) cohort: effect of additional medications on adherence to primary diabetes medicationRachana Shah, Siripoom V McKay, Lorraine E Levitt Katz, et al.
Pediatric Diabetes|April 6, 2017
Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetesAndrea Kriska, Laure El Ghormli, Kenneth C Copeland, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Children (Basel, Switzerland)|November 27, 2025
Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in ChildrenHussein Zaitoon, Aimee D Wauters, Luisa M Rodriguez, et al.
Children (Basel, Switzerland)|May 27, 2026
Reply to Improda, N.; Ballarin, G. Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on "Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. <i>Children</i> 2025, <i>12</i>, 1427"Hussein Zaitoon, Aimee D Wauters, Luisa M Rodriguez, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 7, 2019
Adherence to multiple medications in the TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) cohort: effect of additional medications on adherence to primary diabetes medicationRachana Shah, Siripoom V McKay, Lorraine E Levitt Katz, et al.
Pediatric Diabetes|April 6, 2017
Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetesAndrea Kriska, Laure El Ghormli, Kenneth C Copeland, et al.
Pageof 1